Clinical Trials Sponsored by Genae

Total 285 results

OrbusNeich
Genae

Completed

Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT (REMEDEE-OCT)

Coronary Artery Disease | Atherosclerosis | Acute Coronary Syndrome (ACS) | Myocardial Infarction (MI)

United Kingdom, Netherlands, Finland, Belgium, Switzerland
Javelin Medical
Genae

Active, not recruiting

Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants (CAPTURE2)

Stroke | Atrial Fibrillation

Germany, Spain, Belgium, Czechia, Greece, Hungary, Israel, Poland
Polyganics BV
Genae

Completed

Safety and Performance of a Synthetic Tissue Sealant in Reducing Fluid Leakage in Hepatobiliary and Pancreatic Surgery (SHIELDS)

Pancreatectomy | Hepatic Resection

Germany
GENGE

Recruiting

GENETIC VARIABILITY TO GLP1 TREATMENT (GLP1 treatment)

Obesity | Type 2 Diabetes

Israel
GEn1E Lifesciences

Recruiting

A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)

Respiratory Distress Syndrome, Acute

United States
GEn1E Lifesciences

Completed

Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of GEn1E-1124

Healthy

New Zealand
Cardialen, Inc.
Genae; Five Corners

Terminated

Unpinning Termination Therapy for VT/VF

Ventricular Fibrillation | Ventricular Tachycardia

Australia
Gene Solutions

Recruiting

Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC.

Non Small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Stage IIIC Non-Small Cell Lung Cancer | Tyrosine Kinase Inhibitors

Vietnam
Gene Solutions

Recruiting

Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.

Breast Cancer | Gastric Cancer | Colorectal Cancer | Non Small Cell Lung Cancer | Advanced Cancer | Liver Cancer | Immune Checkpoint Inhibitor

Vietnam
Gene Solutions

Recruiting

Investigate the Prognostic and Predictive Value of ctDNA During Neoadjuvant Chemotherapy for Breast Cancer.

Triple Negative Breast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Breast Cancer Female | Stage III Breast Cancer

Vietnam
Minimus Spine, Inc
genae international,ag

Unknown

Post Market Non-Inferiority Study Comparing Triojection® to Discectomy for Lumbar Disc Herniation

Lumbar Disc Herniation

Greece, Italy, Switzerland
TBF Genie Tissulaire

Not yet recruiting

Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of STT Osteoarthritis

Osteoarthritis Hand

France
TBF Genie Tissulaire

Active, not recruiting

Biological Sling Allograft (UVT) for the Treatment of Urinary Incontinence in Women Presenting With Synthetic Sling Complications

Stress Urinary Incontinence | Female Stress Incontinence

France
TBF Genie Tissulaire

Not yet recruiting

Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of PIP Joint Osteoarthritis

Osteoarthritis Hand

France
TBF Genie Tissulaire

Recruiting

Treatment of Ano-perineal Fistulas Resistant to Surgical Treatment With a Gel and Plug of Wharton's Jelly

Anal Fistula

France
TBF Genie Tissulaire

Recruiting

Use of a Nerve Regeneration Conduit (NerVFIX®) in the Treatment of Nerve Section of the Wrist

Nerve Injury | Nerve Lesion

France
TBF Genie Tissulaire

Completed

Wharton's Jelly Eye Drops in the Treatment of Chronic Keratitis

Corneal Ulcer | Keratitis, Ulcerative

France
TBF Genie Tissulaire

Completed

Use of an Allograft Set-up (SclerFIX) as Replacement of Sclera Graft for Support of Enucleation Implant

Enucleated; Eye | Eye Cancer

France
TBF Genie Tissulaire

Terminated

Amniotic Membrane Visio-AMTRIX in Recurrent Macular Hole

Retinal Detachment | Macular Holes

France
TBF Genie Tissulaire

Terminated

Use of a Disk of Amniotic Membrane (Visio-AMTRIX) in Postoperative Care After PKR

Astigmatism | Myopia | Hypermetropia

France
TBF Genie Tissulaire

Withdrawn

Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Trophic Ulcers

Corneal Ulcer | Persistent Corneal Epithelial Defect
TBF Genie Tissulaire

Terminated

Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Treatment-Resistant Keratitis

Keratitis

France
TBF Genie Tissulaire

Terminated

Comparison of Microfracture Treatment and CARTIPATCH® Chondrocyte Graft Treatment in Femoral Condyle Lesions

Osteochondral Defect | Knee Chondral

Belgium
TBF Genie Tissulaire

Recruiting

Evaluation of SclerFIX Graft in Scleral Thinning After Exeresis of Tumors of the Ocular Surface

Scleral Thinning

France
TBF Genie Tissulaire

Active, not recruiting

Use of a Treated, Devitalized and Sterile Meniscus Segment (MENISC-T) in the Treatment of Scaphotrapeziotrapezoid Osteoarthritis

Osteoarthritis Hand

France
TBF Genie Tissulaire

Terminated

Second Line Treatment of Knee Osteochondral Lesion With Treated Osteochondral Graft (ODPHOENIX2)

Cartilage Injury
TBF Genie Tissulaire

Terminated

OD-PHOENIX in Talus Osteochondral Lesion (TBF3)

Talus Osteochondral Defect

Belgium, Israel
AgNovos Healthcare, LLC
KCR S.A.; genae Group

Completed

CONFIRM - Study of AGN1 LOEP in Patients With Osteoporosis

Osteoporosis

Belgium, Netherlands
Libella Gene Therapeutics

Unknown

Evaluation of Safety and Tolerability of Libella Gene Therapy for Alzheimer's Disease: AAV- hTERT

Alzheimer Disease

Colombia
Sio Gene Therapies

Terminated

Study of OXB-102 (AXO-Lenti-PD) in Patients With Bilateral, Idiopathic Parkinson's Disease (SUNRISE-PD)

Parkinson Disease

United Kingdom, France
Libella Gene Therapeutics

Unknown

Evaluation of Safety and Tolerability of Libella Gene Therapy for the Treatment of Aging: AAV- hTERT

Aging

Colombia
Libella Gene Therapeutics

Unknown

Evaluation of Safety and Tolerability of Libella Gene Therapy for Critical Limb Ischemia: AAV- hTERT

Critical Limb Ischemia

Colombia
Gene Surgery LLC

Recruiting

Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid

Melanoma | Sarcoma | Uterine Cervical Neoplasms | Breast Neoplasms | Squamous Cell Carcinoma of Head and Neck | Vulvar Neoplasms | Anus Neoplasms | Penile Neoplasms

Russian Federation
Elixir Medical Corporation
Massachusetts General Hospital; Syntactx; Genae

Completed

The DESappear Study: Drug Eluting Scaffold (DESappear)

Peripheral Vascular Disease

New Zealand, Austria, Germany, Belgium
Wise S.r.l.
Fondazione Don Carlo Gnocchi Onlus; Genae

Completed

WISE Cortical Strip for Intraoperative Neurophysiological Monitoring (WIN)

Epilepsy | Brain Tumor Adult

Switzerland, Germany, Italy
Taysha Gene Therapies, Inc.

Withdrawn

A Study of the Natural Course of SURF1 Deficiency

Leigh Syndrome

United States
Gene PreDiT
Blueclinical, Ltd.

Terminated

Influence of Carboxypeptidase D (CPD) Gene on Body Weight and Fat Mass Reduction by Perindopril in Obese Subjects (GPD-01-01)

Obesity

Portugal
Novartis Gene Therapies

Terminated

Study of Intrathecal Administration of Onasemnogene Abeparvovec-xioi for Spinal Muscular Atrophy (STRONG)

Spinal Muscular Atrophy

United States
Novartis Gene Therapies

Completed

Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1

Spinal Muscular Atrophy 1

United States
Novartis Gene Therapies

Completed

Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1 (STR1VE)

Gene Therapy | SMA - Spinal Muscular Atrophy

United States
Novartis Gene Therapies

Completed

Single-Dose Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1 (STRIVE-EU)

SMA

France, United Kingdom, Italy, Belgium
Taysha Gene Therapies, Inc.

Recruiting

Safety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study)

Rett Syndrome

United States, United Kingdom
Taysha Gene Therapies, Inc.

Recruiting

Safety and Efficacy of TSHA-102 in Adult Females With Rett Syndrome (REVEAL Adult Study)

Rett Syndrome

United States, Canada
Novartis Gene Therapies

Active, not recruiting

Long-Term Follow-up Study for Patients From AVXS-101-CL-101 (START)

Spinal Muscular Atrophy 1

United States
Novartis Gene Therapies

Active, not recruiting

Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi

SMA | Spinal Muscular Atrophy Type II | Spinal Muscular Atrophy Type I | Spinal Muscular Atrophy Type III

United States, Belgium, France, Japan, United Kingdom, Italy, Taiwan, Australia, Canada
American Gene Technologies International Inc.

Unknown

Developing a Functional Cure for HIV Disease: Clinical Specimen Collection From HIV Positive Individuals

HIV Infections

United States
Imperial College London
Gene Logic

Completed

Regulation of Inflammatory Mediators in Chronic Obstructive Pulmonary Disease

Emphysema | COPD

United Kingdom
American Gene Technologies International Inc.

Completed

Study to Evaluate the Safety of a Gene and Cell Therapy Product in Participants With HIV That is Well-Controlled on Antiretroviral Therapy

HIV

United States
American Gene Technologies International Inc.

Enrolling by invitation

An Antiretroviral Treatment Interruption (ATI) Study to Evaluate the Impact of Genetically Modified Autologous Cells (AGT103-T) to Suppress Human Immunodeficiency Virus Replication in the Absence of Antiretroviral Therapy

HIV

United States
American Gene Technologies International Inc.

Enrolling by invitation

Long-term Follow-up of Study Participant Treated With Lentiviral-Based Genetically Modified Autologous Cell Product ,AGT103-T

HIV

United States

Clinical Trials Sponsored by Genae

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations